Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

Viatris

Status: Completed

Conditions: Glaucoma, Open-angle

Treatments: Drug: Xalacom

Study type: Observational

Funder types: Industry

Identifiers

NCT00801437

A6641053

Details and patient eligibility

About

This study is designed to evaluate the safety and tolerability of Xalacom in patients with primary glaucoma

Full description

according to physicians decision, patients who met inclusion and exclusion criteria and sign the ICD

Enrollment: 457 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• primary open angle glaucoma
• ocular hypertension
• age >18 years

Exclusion criteria

• bradycardia
• obstructive pulmonary disease
• hypersensitivity to the drug

Trial design

457 participants in 1 patient group

Xalacom treatment

Description:

patients with primary glaucoma

Treatment:

Drug: Xalacom